Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Kay B. Brosnihan
Introduction
Kay B. Brosnihan, an accomplished inventor based in Winston-Salem, NC, has made significant strides in the medical field, specifically in the treatment of hypertension. With a keen focus on innovation, she has developed a groundbreaking process that holds promise for improving the lives of many individuals suffering from this prevalent condition.
Latest Patents
Brosnihan is credited with one notable patent: a process and composition for treating hypertension. This invention introduces the use of Z-Pro-prolinal (ZPP), a composition that effectively treats hypertension in mammals. Recent findings indicate that ZPP serves as an inhibitor of Ang(1-7), a biologically active hypertensive agent within the renin-angiotensin system (RAS). By reducing the formation of Ang-(1-7), Brosnihan's treatment has shown a significant decrease in blood pressure, without affecting heart rate or other circulatory functions. This novel approach presents a promising advancement in hypertension therapy.
Career Highlights
Kay B. Brosnihan is associated with The Cleveland Clinic Foundation, a prestigious institution known for its dedication to medical research and innovation. Her work exemplifies the commitment to enhancing healthcare outcomes through inventive solutions.
Collaborations
In her endeavors, Brosnihan has collaborated with esteemed colleagues Carlos M. Ferrario and Robson A. Santos. Their combined expertise has undoubtedly contributed to the development and effectiveness of her patent, demonstrating the importance of teamwork in advancing medical technologies.
Conclusion
Kay B. Brosnihan's contributions to the field of hypertension treatment reflect her dedication to innovation and excellence in medical research. Her patent on Z-Pro-prolinal (ZPP) highlights the potential for new therapeutic strategies, ultimately aiming to improve patient care. As she continues her work with The Cleveland Clinic Foundation, the medical community eagerly anticipates further advancements from her innovative pursuits.